Medicine guide
Crixivan
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Indinavir
- Made by
- Merck Sharp & Dohme B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Crixivan is indicated in combination with antiretroviral nucleoside analogues for the treatment of HIV-1 infected adults.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Merck Sharp & Dohme B.V. |
|---|---|
| Active substance | Indinavir |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J05AE02 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 1996-10-04 |
| Last updated by the regulator | 2022-07-12 |
| EMA product number | EMEA/H/C/000128 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).